Academic Journal
Q1Frontiers of Medicine
About Frontiers of Medicine
About Frontiers of Medicine
Frontiers of Medicine is a peer-reviewed scholarly journal published by Springer Science + Business Media (China). It focuses on Q1. Publication coverage spans 2011-2025.
Key indicators: ISSN 2095-0225, 2095-0217; H-index 70.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (70): Strong citation impact — 70 articles cited at least 70 times each, reflecting solid influence.
Publishing in Frontiers of Medicine
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Frontiers of Medicine?
2095-0225, 2095-0217.
Who publishes Frontiers of Medicine?
Springer Science + Business Media.
What are Frontiers of Medicine's metrics?
H-index 70.
Is Frontiers of Medicine peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
RNA modifications and cancer; Liver Disease Diagnosis and Treatment; Immune Cell Function and Interaction; COVID-19 Clinical Research Studies; SARS-CoV-2 and COVID-19 Research; Epigenetics and DNA Methylation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,390.00 USD; 3,690.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study
Yun Zhou, Jian Zhou, Yin Wang, Ji-Bin Li et al.
2025-10 · DOI: 10.1007/s11684-025-1155-1Precision medicine for advanced biliary tract cancer in China: current status and future perspectives
Zhen Huang, Wen Zhang, Yongkun Sun, Dong Yan et al.
2025-10 · DOI: 10.1007/s11684-025-1144-4RRS1 regulates proliferation, migration, and invasion of HTR-8/SVneo human trophoblasts
Yixuan Wu, Yao Li, Jing Wang, Qianying Guo et al.
2025-10 · DOI: 10.1007/s11684-025-1150-6Innovation and development of stent retrievers in acute ischemic stroke
Nan Zhang, Hongye Xu, Hongjian Zhang, Hongyu Ma et al.
2025-10 · DOI: 10.1007/s11684-025-1160-4Perspective on strengthening dementia prevention and control system: a comprehensive framework for national health
Bin Cong, Hengge Xie, Yongan Sun, Jingnian Ni et al.
2025-10 · DOI: 10.1007/s11684-025-1154-2Particulate matter exposure and end-stage renal disease risk in IgA nephropathy
Yilin Chen, Huan Zhou, Siqing Wang, Lingqiu Dong et al.
2025-10 · DOI: 10.1007/s11684-025-1162-2Global, regional and national burden and trends of congenital musculoskeletal and limb deformities among under-5 children from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Qinglin Yang, Zhuanmei Jin, Yongping Wang
2025-10 · DOI: 10.1007/s11684-025-1156-0Predictive biomarkers for immunotherapy in nasopharyngeal carcinoma: from tumor microenvironment to macroenvironment
Saiwei Huang, Yelin Liang, Na Liu, Jun Ma et al.
2025-10 · DOI: 10.1007/s11684-025-1151-5Exogenous spexin aggravates renal ischemia reperfusion injury and triggers toxicity in healthy kidneys
Kadri Kulualp, Meltem Kumaş Kulualp, Zeynep Semen, Gökçen Güvenç Bayram et al.
2025-10 · DOI: 10.1007/s11684-025-1159-xChina’s biosafety/biosecurity governance: evolution, challenges, and architecture design
Kaiyuan Min, Yi Zhang, Jiangfeng Liu, Juntao Yang et al.
2025-10 · DOI: 10.1007/s11684-025-1158-yInsights into potential therapeutic approaches for long COVID
Jingya Zhao, Yingqi Lyu, Jieming Qu
2025-10 · DOI: 10.1007/s11684-025-1149-zLactate and lactylation in tumor immunity
Liu Song, Lingjuan Sun, Song Chen, Peixiang Lan et al.
2025-10 · DOI: 10.1007/s11684-025-1148-0Understanding pain heterogeneity in osteoarthritis patients: a narrative review
Lin Li, Xiwei Fan, Ross Crawford, Xinzhan Mao et al.
2025-10 · DOI: 10.1007/s11684-025-1143-5Betaine: an exercise mimetics for healthy aging?
Yiliang Zhang, Xiaomin Liu, Yan Wang
2025-08 · DOI: 10.1007/s11684-025-1157-zSuppressing DBNDD2 promotes neuron growth and axon regeneration in adult mammals
Lan Zhang, Yucong Wu, Zhuheng Zhong, Tianyun Chen et al.
2025-08 · DOI: 10.1007/s11684-025-1146-2Development of therapeutic cancer vaccines based on cancer immunity cycle
Jing Zhang, Yiyuan Zheng, Lili Xu, Jing Gao et al.
2025-08 · DOI: 10.1007/s11684-025-1134-6A critical perspective on patient activation through integrative healthcare counseling in oncology
Carlos M. Ardila, Pradeep K. Yadalam
2025-08 · DOI: 10.1007/s11684-025-1152-4Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting
Haohua Zhu, Song Huang, Xingsheng Hu
2025-08 · DOI: 10.1007/s11684-025-1140-8Response to “A critical perspective on patient activation through integrative healthcare counselling in oncology”, based on the “CCC-Integrativ” study
Jan Valentini, Daniela Froehlich, Cornelia Mahler, Stefanie Joos et al.
2025-08 · DOI: 10.1007/s11684-025-1153-3Crigler-Najjar syndrome type 2 complicating cholecystitis in a patient with UGT1A1 gene double homozygous mutations
Jianhui Zhang, Rongrong Chen, Xiang Chen, Ying Chen et al.
2025-08 · DOI: 10.1007/s11684-025-1142-6Reviews
Community Reviews
Version History
October 9, 2026 at 7:50 pm
September 25, 2026